Acceptability measures of water, sanitation and hygiene interventions in low- and middle-income countries, a systematic review (Publications)
BACKGROUND: Inadequate access to water, sanitation, and hygiene (WASH) is an environmental risk factor for poor health outcomes globally, particularly for children in low- and middle-income countries
COVID-19 vaccine booster strategies in light of emerging viral variants: frequency, timing, and target groups (Publications)
BACKGROUND: Vaccinations have reduced severe burden of COVID-19 and allowed for lifting of non-pharmaceutical interventions. However, with immunity waning alongside emergence of more transmissible var
Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: an observational study of cardiopulmonary... (Publications)
BACKGROUND: Cardiopulmonary Exercise Testing (CPET) provides a comprehensive assessment of pulmonary, cardiovascular and musculosceletal function. Reduced CPET performance could be an indicator for ch
Pharmacokinetics of ascending doses of praziquantel in adults infected with <em>Opisthorchis felineus</em> in Western Siberia, Russian Federation (Publications)
Opisthorchiasis due to the liver fluke Opisthorchis felineus is highly prevalent in rural regions of Western Siberia, causing severe liver and bile duct maladies. Praziquantel administered as a three-
Multi-sensor data collection for personal exposure monitoring: ICARUS experience (Publications)
As part of the ICARUS (Integrated Climate forcing and Air pollution Reduction in Urban Systems) H2020 EU project, sampling campaigns took place in seven European cities (Athens, Basel, Brno, Ljubljana
The Chronic Diseases Clinic of Ifakara (CDCI): establishing a model clinic for chronic care delivery in rural sub-Saharan Africa (Publications)
The rollout of antiretroviral drugs in sub-Saharan Africa to address the huge health impact of the HIV pandemic has been one of the largest projects undertaken in medical history and is an unprecedent
Accelerated development of malaria monoclonal antibodies (Publications)
L9LS, a potent and safe antimalarial monoclonal antibody, demonstrated 88% protective efficacy against infection in a phase 1 trial in healthy adults.(1) These promising results are the first of many
Pre-treatment HIV-1 drug resistance in antiretroviral therapy-naive adults in Eastern Africa: a systematic review and meta-analysis (Publications)
BACKGROUND: Pre-treatment HIV drug resistance (PDR) may result in increased risk of virological failure and acquisition of new resistance mutations. With recently increasing ART coverage and periodic
